PLEASE JOIN US THURSDAY 21 SEPTEMBER AT: 3PM BST | 4 PM CEST | 10 AM EDT | 7 AM PDT FOR:
Unlocking the potential of FFPE tissues for investigating Mode of Action of Adverse Outcomes & Improving Predictive Capability
Now available on demand
Within routine safety assessment studies in rodents, it is not uncommon to observe adverse events that raise questions regarding the safety of the candidate compound.
If this is the case, should the compound be shelved or allowed to proceed? If the toxicity might be species specific, there is a rationale for investigating the mechanism(s) of toxicity as it/they may not be relevant to humans.
While new prospective studies could be performed to generate samples to investigate the mechanisms of toxicity, it is also possible to perform investigative studies on archival tissue samples collected as part of the original regulatory studies.
This approach saves time and money and makes it possible to benchmark findings to the particular dose and tissue where the toxicity occurred; retrospective studies can also inform the design of better prospective studies to test a MOA hypothesis.
Within this webinar , we will present data on novel approaches that we have applied to archival FFPE samples for hypothesis generation and mode of action (MOA) studies and also for the identification of biomarkers that can predict toxicity outcomes.